CAROLINE BROWNING: Open Payments
NPI 1245945237 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 25 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $53 |
| Ardelyx, Inc. | 2 | $52 |
| Lilly USA, LLC | 3 | $51 |
| Insulet Corporation | 2 | $46 |
| Novo Nordisk Inc | 2 | $44 |
| PFIZER INC. | 2 | $37 |
| Dynavax Technologies Corporation | 2 | $35 |
| ABBVIE INC. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: TRELEGY ELLIPTA, IBSRELA, Omnipod, REXULTI, MOUNJARO, Heplisav-B, UBRELVY, Rybelsus.
Industry payments across KY — which companies pay providers there.
